Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT01005485

Molecular and Morphologic Characterization of Circulating Endothelial Cells

Comprehensive Molecular and Morphologic Characterization of Circulating Endothelial Cells

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
664 (actual)
Sponsor
Scripps Translational Science Institute · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The primary hypothesis of this study is that circulating endothelial cells (CECs) harbor key genetic and structural characteristics predisposing individuals to acute atherosclerotic plaque rupture and heart attack.

Detailed description

Endothelial injury and inflammation are pivotal underlying processes that put patients at risk for catastrophic vascular events including acute myocardial infarction (heart attack) and stroke. We seek to accelerate scientific discovery through clinically meaningful, innovative translational research, and are collaborating in a trans-disciplinary effort to define the DNA sequence of CECs and that of germ line DNA, along with RNA sequencing, mRNA expression profiling, and ultrastructural characterization of CECs in order to better understand the mechanisms leading to acute arterial plaque rupture and embolization of arterial endothelial cells in patients with acute myocardial infarction. This will enable us to create a molecular fingerprint that could identify and preempt individuals from suffering from such debilitating vascular conditions.

Conditions

Timeline

Start date
2010-01-01
Primary completion
2017-04-01
Completion
2025-12-01
First posted
2009-11-02
Last updated
2025-01-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01005485. Inclusion in this directory is not an endorsement.